Recursion Pharmaceuticals
Nasdaq: RXRXOn BioBridgeX
- Raised $246 million (2020)
- 7 clinical trials, 3 active
- Research grants: $5.8 million
- Founded 2013
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Biotech companies 4,292Medical device companies 3,738Pharmaceutical companies 2,134Medical device contract manufacturers 1,148Diagnostics companies 493Contract research organizations 140CDMOs 123Laboratory testing companies 66Life science instrument companies 48Contract sterilization companies 47Research companies 37
AbbVie Inc.
NYSE: ABBV
- Raised $3.8 billion (2016)
- 1554 clinical trials, 257 active
- FDA-cleared or approved devices
- 10 FDA-registered drug sites
Vericel Corp
Nasdaq: VCEL
- Raised $40 million (2012)
- 14 clinical trials, 2 active
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
GLAUKOS Corp
NYSE: GKOS
- Raised $30 million (2013)
- 67 clinical trials, 11 active
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Mobia Medical, Inc.
Nasdaq: MOBI
- Raised $32 million (2025)
- 7 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $8.3 million
SAB Biotherapeutics, Inc.
Nasdaq: SABS
- Raised $175 million (2025)
- 6 clinical trials, 2 active
- 2 FDA-registered drug sites
- Research grants: $6.1 million
Adaptive Biotechnologies Corp
Nasdaq: ADPT
- Raised $195 million (2015)
- 8 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $5 million
Pulse Biosciences, Inc.
Nasdaq: PLSE
- Raised $50 million (2021)
- 14 clinical trials, 5 active
- FDA-cleared or approved devices
- Research grants: $606,950
Savara Inc
Nasdaq: SVRA
- Raised $27 million (2020)
- 25 clinical trials, 2 active
- 1 FDA-registered drug site
- Research grants: $5 million
Crinetics Pharmaceuticals, Inc.
Nasdaq: CRNX
- Raised $350 million (2024)
- 19 clinical trials, 6 active
- Research grants: $16 million
Artivion, Inc.
NYSE: AORT
- Raised $20 million (2020)
- 22 clinical trials, 4 active
- FDA-cleared or approved devices
- Research grants: $2.4 million
PAVmed Inc.
Nasdaq: PAVM
- Raised $30 million (2026)
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $3.6 million
Agilent Technologies
NYSE: AOn BioBridgeX
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
- Research grants: $13,019
Medtronic Inc
- Raised $21 million (2013)
- 141 clinical trials, 16 active
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
Cartesian Therapeutics, Inc.
Nasdaq: RNAC
- Raised $130 million (2024)
- 12 clinical trials, 5 active
- Research grants: $19 million
- Founded 2007
Sintx Technologies, Inc.
Nasdaq: SINT
- Raised $5.5 million (2014)
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $7.6 million
Axogen, Inc.
Nasdaq: AXGN
- Raised $1 million (2011)
- 10 clinical trials, 4 active
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Karyopharm Therapeutics Inc.
Nasdaq: KPTI
- Raised $165 million (2022)
- 39 clinical trials, 9 active
- Research grants: $4.4 million
- Founded 2008
Stryker Corp
NYSE: SYK
- Raised $2.9 million (2009)
- 6 clinical trials
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Dare Bioscience, Inc.
Nasdaq: DARE
- Raised $1.7 million (2023)
- 12 clinical trials, 3 active
- Research grants: $14 million
- Founded 2005
Cellectar Biosciences, Inc.
Nasdaq: CLRB
- Raised $25 million (2023)
- 13 clinical trials, 5 active
- Research grants: $10 million
Achieve Life Sciences, Inc.
Nasdaq: ACHV
- Raised $19 million (2022)
- 31 clinical trials, 1 active
- Research grants: $5.6 million
Inhibikase Therapeutics, Inc.
Nasdaq: IKT
- Raised $1 million (2026)
- 8 clinical trials, 2 active
- Research grants: $25 million
- Founded 2025
Marker Therapeutics, Inc.
Nasdaq: MRKR
- Raised $16 million (2024)
- 7 clinical trials, 3 active
- Research grants: $14 million
Cytosorbents Corp
Nasdaq: CTSO
- Raised $745,000 (2013)
- 9 clinical trials, 2 active
- 1 FDA-registered device site
- Research grants: $8.5 million
Lyra Therapeutics, Inc.
OTC: LYRA
- Raised $50 million (2023)
- 5 clinical trials
- Research grants: $9.6 million
- Founded 2005
Annexon, Inc.
Nasdaq: ANNX
- Raised $130 million (2022)
- 16 clinical trials, 3 active
- Research grants: $2.6 million
- Founded 2011
Longeveron Inc.
Nasdaq: LGVN
- Raised $16 million (2026)
- 10 clinical trials, 1 active
- Research grants: $10 million
- Founded 2014
Celldex Therapeutics, Inc.
Nasdaq: CLDX
- Raised $63 million (2016)
- 47 clinical trials, 7 active
- Research grants: $4 million
Cognition Therapeutics Inc
Nasdaq: CGTX
- Raised $1.6 million (2018)
- 13 clinical trials, 1 active
- Research grants: $20 million
- Founded 2007
Agenus Inc
Nasdaq: AGEN
- Raised $30 million (2019)
- 35 clinical trials, 6 active
- Research grants: $1.9 million
Intuitive Surgical Inc
Nasdaq: ISRG
- 61 clinical trials, 17 active
- FDA-cleared or approved devices
- Research grants: $4.6 million
Mannkind Corp
Nasdaq: MNKD
- Raised $59 million (2013)
- 59 clinical trials, 2 active
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Serina Therapeutics, Inc.
NYSE: SER
- Raised $10 million (2023)
- 2 clinical trials, 1 active
- Research grants: $4.8 million
- Founded 2017
Edwards Lifesciences Corp
NYSE: EW
- Raised $35 million (2018)
- 128 clinical trials, 46 active
- FDA-cleared or approved devices
Protagonist Therapeutics, Inc
Nasdaq: PTGX
- Raised $17 million (2015)
- 13 clinical trials, 2 active
- Research grants: $6.3 million
Dynavax Technologies Corp
- Raised $181,000 (2010)
- 25 clinical trials, 2 active
- 1 FDA-registered drug site
- Research grants: $7.4 million
Lisata Therapeutics, Inc.
Nasdaq: LSTA
- Raised $25 million (2021)
- 17 clinical trials
- Research grants: $4 million
Galera Therapeutics, Inc.
OTC: GRTX
- Raised $2.9 million (2025)
- 17 clinical trials
- Research grants: $2.2 million
- Founded 2012
Vaxcyte, Inc.
Nasdaq: PCVX
- Raised $110 million (2020)
- 9 clinical trials, 5 active
- Research grants: $392,126
- Founded 2013
Spero Therapeutics, Inc.
Nasdaq: SPRO
- Raised $9 million (2022)
- 22 clinical trials
- Research grants: $2 million
- Founded 2013
Champions Oncology
Nasdaq: CSBROn BioBridgeX
- Raised $14 million (2015)
- 1 clinical trial
- Research grants: $2 million
Opus Genetics, Inc.
Nasdaq: IRD
- Raised $26 million (2024)
- 3 clinical trials, 3 active
- Research grants: $4.5 million
- Founded 2021
PTC Therapeutics, Inc.
Nasdaq: PTCT
- Raised $36 million (2023)
- 66 clinical trials, 5 active
- Research grants: $6.2 million
Heartflow, Inc.
Nasdaq: HTFL
- Raised $65 million (2019)
- 16 clinical trials, 5 active
- FDA-cleared or approved devices
- Research grants: $338,268
Alto Neuroscience, Inc.
NYSE: ANRO
- Raised $50 million (2025)
- 12 clinical trials, 4 active
- Research grants: $6.4 million
- Founded 2019
NeuroSigma, Inc.
- Raised $12 million (2016)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $12 million
Solventum Corp
NYSE: SOLV
- 64 clinical trials, 2 active
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
Becton Dickinson & Co
NYSE: BDX
- 66 clinical trials, 6 active
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
Humacyte, Inc.
Nasdaq: HUMA
- Raised $150 million (2018)
- 15 clinical trials, 4 active
- 1 FDA-registered drug site
- Research grants: $7.5 million
Published company profiles only; counts update daily. Data licences